Neffen, Hugo http://orcid.org/0000-0002-7362-6405
Moraes, Felipe
Viana, Karynna
Di Boscio, Valentina
Levy, Gur
Vieira, Claudia
Abreu, Gabriela
Soares, Claudia
Funding for this research was provided by:
GSK (PRJ2544)
Article History
Received: 12 March 2019
Accepted: 9 June 2019
First Online: 9 July 2019
Ethics approval and consent to participate
: This is a reanalysis of a previously conducted study – the Asthma Control in Latin America (ASLA) study – with no additional data collection. The previous ASLA study was approved by applicable institutional review boards/independent ethics committees and was conducted in accordance with the Declaration of Helsinki. All institutional review boards/independent ethics committees have been listed in the Additional file InternalRef removed. Prior to study participation, all patients aged 18 years or older provided written informed consent; patients aged 12 to 18 years provided a written assent form, and their parents or legal guardians (for emancipated minors) provided written informed consent, in accordance with local requirements.
: Not applicable.
: HN has nothing to disclosure; KV and FM are GSK employees; CV and GA are GSK complementary employees. CS, GL and VDB are GSK employees and holds GSK stocks.